Quantitative assessment of spasticity in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

Journal of NeuroVirology

Volumn 11, Issue 1, 2005, Pages 70-73

  Zunt, Joseph R ^a,d   Montano, S M ^b   Alarcon J O V ^c   Longstreth Jr , W T ^a   Price, R ^a   Holmes, K K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HTLV I; Myelopathy; Spasticity

Indexed keywords

MUSCLE RELAXANT AGENT;

ACHILLES TENDON; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUSCLE TONE; NEUROLOGIC EXAMINATION; PARAPLEGIA; PERU; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SEX DIFFERENCE; SOLEUS MUSCLE; SPASTICITY; SPINAL CORD DISEASE;

ADULT; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PARAPARESIS, TROPICAL SPASTIC;

EID: 16244415899     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280590900571     Document Type: Article

References (10)

1. Bohannon RW, Smith MB (1987). Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207.
2. de The G, Bomford R (1993). An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 9: 381-386.
3. Lehmann JF, Price R, deLateur BJ, Hinderer S, Traynor C (1989). Spasticity: quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil 70: 6-15.
4. Leon SF, Costa CM, Gaffga N (1997). Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. A meta-analysis on 2811 patients. Arq Neuropsiquiatr 55: 530-535.
5. Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A (1998). Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 17: 167-170.
6. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, Nemo G (1997). HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 48: 315-320.
7. Osame M (1999). [The recent advances of HAM/TSP research]. Rinsho Shinkeigaku 39: 1200-1202.
8. Price R, Bjornson KF, Lehmann JF, McLaughlin JF, Hays RM (1991). Quantitative measurement of spasticity in children with cerebral palsy. Dev Med Child Neurol 33: 585-595.
9. Roman GC, Roman LN (1988). Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome. J Neurol Sci 87: 121-138.
10. Zunt JR, Alarcon JO, Montano S, Longstreth WT Jr, Price R, Holmes KK (1999). Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection. Neurology 53: 386-390.